A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, brain disorder, central nervous system cancer, central nervous system disorder, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer	Recruiting	Phase 2	2026-10-06		NCT07428616

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Exelixis	77

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baptist Health Miami Cancer Institute	Miami	United States	3
Brown University Health Cancer Institute	Providence	United States	1
Duke University	Durham	United States	160
Inova Center for Personalized Health	Fairfax	United States	1
LSU Health Science Center	New Orleans	United States	1
Massachusetts General Hospital	Boston	United States	1015
Mayo Clinic_Arizona	Phoenix	United States	1
Mayo Clinic_Jacksonville	Jacksonville	United States	1
Mayo Clinic_Rochester	Rochester	United States	1
Memorial Sloan-Kettering Cancer Center	New York	United States	63
Northwestern University	Chicago	United States	727
Providence - Saint John's Health Center	Santa Monica	United States	1
Tampa General Hospital	Tampa	United States	1
The Ohio State University College of Medicine (OSUCOM)	Columbus	United States	2
University of Alabama	Birmingham	United States	29
UT Health San Antonio Mays Cancer Center	San Antonio	United States	4
UT MD Anderson Cancer Center	Houston	United States	204
UW Carbone Cancer Center	Madison	United States	11
Washington University School of Medicine	St Louis	United States	895